Original language | English |
---|---|
Pages (from-to) | 875-878 |
Number of pages | 4 |
Journal | Gut |
Volume | 73 |
Issue number | 5 |
Early online date | 31 Mar 2023 |
DOIs | |
Publication status | Published - May 2024 |
Scopus Subject Areas
- Gastroenterology
User-Defined Keywords
- COLONIC MICROFLORA
- INTESTINAL BACTERIA
- OBESITY
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Gut, Vol. 73, No. 5, 05.2024, p. 875-878.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Mixed-donor faecal microbiota transplantation was associated with increased butyrate-producing bacteria for obesity
AU - Xu, Zhilu
AU - Mak, Joyce Wing Yan
AU - Lin, Yu
AU - Yang, Keli
AU - Liu, Qin
AU - Zhang, Fen
AU - Lau, Louis
AU - Tang, Whitney
AU - Ching, Jessica YL
AU - Tun, Hein M
AU - Chan, Paul
AU - Chan, Francis K L
AU - Ng, Siew C
N1 - Funding Information: FKLC is the co-founder, non-executive Board Chairman and shareholder of GenieBiome Ltd. FKLC is Board Member of CUHK Medical Centre. FKLC has received fees as an advisor and honoraria as a speaker for Eisai Co. Ltd., AstraZeneca, Pfizer Inc., Takeda Pharmaceutical Co., and Takeda (China) Holdings Co. Ltd. FKLC receives patent royalties through his affiliated institutions in the applications of microbiome. SCN is a scientific co-founder and shareholder of GenieBiome Ltd. SCN has served as an advisory board member for Pfizer, Ferring, Janssen, and Abbvie and received honoraria as a speaker for Ferring, Tillotts, Menarini, Janssen, Abbvie, and Takeda. SCN has received research grants through her affiliated institutions from Olympus, Ferring, and Abbvie. SCN receives patent royalties through her affiliated institutions in the applications of microbiome. ZX, and WT are part-time employee of GenieBiome Ltd. JYLC received personal fees from GenieBiome Ltd. SCN, FKLC, ZX, QL are named inventors of patent applications held by the CUHK and MagIC that covers the therapeutic and diagnostic use of microbiome related to FMT or obesity.All other co-authors declare no competing interests. Funding Information: This study received funding support from InnoHK, The Government of Hong Kong, Special Administrative Region of the People’s Republic of China (grant number not available (NA)).
PY - 2024/5
Y1 - 2024/5
KW - COLONIC MICROFLORA
KW - INTESTINAL BACTERIA
KW - OBESITY
UR - http://www.scopus.com/inward/record.url?scp=85152203054&partnerID=8YFLogxK
U2 - 10.1136/gutjnl-2022-328993
DO - 10.1136/gutjnl-2022-328993
M3 - Letter
SN - 0017-5749
VL - 73
SP - 875
EP - 878
JO - Gut
JF - Gut
IS - 5
ER -